Phase 2 Clinical Trial Pipeline Insights
To provide more clarity, Paolo Capogrosso, MD, of the University Vita-Salute San Raffaele, in Milan, Italy, and his colleagues assessed the sociodemographic and clinical characteristics of 439 men seeking medical help for newly-developed erectile dysfunction
between January 2010 and June 2012 at a single academic outpatient clinic.
In the only good published study, 30 Korean men with erectile dysfunction
who took 1,800 mg of Korean red ginseng every day for three months were more likely to report greater sexual desire and erectile function than 30 similar men who took a placebo.
The average Hamilton Depression rating scale score also significantly improved to a mean of 6 among the 58 men whose erectile dysfunction
had responded to treatment.
Identify and understand important and diverse types of therapeutics under development for Erectile Dysfunction
A man with erectile dysfunction
should not be seen by a urologist, but by a cardiologist," according to Dr.
Licensing Activities / Partnerships in the Global Erectile Dysfunction
Treatment of phosphodiesterase 5 inhibitors shows insufficient effectiveness in the treatment of post-prostatectomy ED and it is believed that the transplantation of stem cells cultivated on the surface of nanofibrous meshes can promote cavernous neuronal regeneration and repair erectile dysfunction
While previous studies have shown that men with severe erectile dysfunction
are more likely than men with no erectile difficulties to have cardiovascular events such as heart disease or stroke, this study is the first to review gradients of erectile dysfunction
from none, to mild, moderate and severe forms.
Fore Pharma's latest report Global Erectile Dysfunction
Drug Pipeline Capsule - 2011' is an outline of all the key research and development (R&D) activities of the global erectile dysfunction
6 Erectile Dysfunction
Market: Implications for Future Market Competition
- Drug Pipeline Analysis and Market Forecasts to 2016 is an essential source of information and analysis on the global erectile dysfunction
A single injection directly into the penis of men with erectile dysfunction
of a gene that regulates ion channel activity and affects smooth muscle function was shown to be safe and promising for treating erectile dysfunction
in a ground-breaking study published online ahead of print in the December 2006 issue (Volume 17, Number 12) of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc.
com/reports/c32264) has announced the addition of Erectile Dysfunction
Drugs in Japan: Marketing Issues and Strategies to their offering.
The upgrade is also due in part to the small stock float below 2 million, the companies' latest herbal product to fight Erectile Dysfunction
(ED) and their near-term pipeline of high revenue generating products in the areas of weight loss and depression.